Skip to content
Screener

Boston Scientific BSX Inventory step-up amortization

Inventory step-up amortization at other companies

Amcor logo
AmcorAMCR
$33.25M—
Charles River Laboratories logo
Charles River LaboratoriesCRL
$6.13M-11.6%
Charles River Laboratories logo
Charles River LaboratoriesCRL
$6.13M-11.6%
Charles River Laboratories logo
Charles River LaboratoriesCRL
$1.5M-64.3%
Charles River Laboratories logo
Charles River LaboratoriesCRL
$1.5M-64.3%
Viavi Solutions Inc. logo
Viavi Solutions Inc.VIAV
$900K-47.1%

Other financials

Income statement

See full
Revenue$5.4B+7.5%
Gross profit$3.8B+12.4%
Operating income$1.2B+43.8%
Net income$907.0M+14.1%
EPS (diluted)$0.61+15.1%

Balance sheet

See full
Cash & equivalents$850.0M+146%
Total debt$659.0M-94.1%
Total equity$25.9B+16.4%
Total assets$44.4B+10.5%

Cash flow

See full
Operating cash flow$348.0M-35.7%
CapEx$177.0M-5.3%
Free cash flow$171.0M-51.7%

Valuation

See full
Market cap$69.19B-54.6%
P/E18.9×-42.3×
P/S3.3×-5.0×

Profitability

See full
Gross margin69.9%+1.7pp
Operating margin19.8%+2.8pp
Net margin17.5%+4.0pp
FCF margin16.9%-0.3pp

Returns & leverage

See full
Return on equity14.8%+5.2pp
Debt / equity0×-0.5×
Current ratio1.9×+0.4×

Where this comes from

Reported directly by Boston Scientific in its filing.

Tagged under the XBRL concept bsx:InventoryStepUpAmortization.

The source filing: Boston Scientific’s 10-Q, filed May 1, 2026.

Filed
May 1, 2026, 6:25 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0000885725-26-000033
(in millions)Three Months Ended March 31, 2026Three Months Ended March 31, 2025
Stock-based compensation expense8374
Net loss (gain) on investments and notes receivable(158)28
Contingent consideration net expense (benefit)(30)5
Inventory step-up amortization281
Other, net27(7)
Increase (decrease) in operating assets and liabilities, excluding purchase accounting:
Trade accounts receivable(117)(107)
Inventories(177)(109)

ITEM 1. CONSOLIDATED FINANCIAL STATEMENTS

FAQ

What is Boston Scientific's inventory step-up amortization?
Boston Scientific (BSX) reported inventory step-up amortization of $2M in Q1 2026.
How has Boston Scientific's inventory step-up amortization changed year-over-year?
Boston Scientific's inventory step-up amortization decreased by 97.5% year-over-year, from $81M to $2M.
What is the long-term trend for Boston Scientific's inventory step-up amortization?
Over 4 years (2021 to 2025), Boston Scientific's inventory step-up amortization has grown at a 40.4% compound annual growth rate (CAGR), from $34M to $132M.
What does inventory step-up amortization mean?
This is the non-cash expense related to the fair value adjustment of acquired inventory at the time of an acquisition. It represents the difference between the cost basis of the acquired inventory and its fair market value, expensed as the inventory is sold.

Ask your AI about Boston Scientific's inventory step-up amortization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude